{"schema":"hottub-news/story/v1","story":"st_esgaqwqh3y7x44xr5qkq","title":"Tiziana doses first three patients in ALS trial of nasal antibody foralumab","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/tiziana-doses-first-three-patients-in-als-trial-of-nasal-antibody-esgaqwqh3y","count":1,"items":[{"id":"n_esgaqwqh3y7x44xr5qkq","seq":448849,"kind":"article","title":"Tiziana doses first three patients in ALS trial of nasal antibody foralumab","url":"https://www.proactiveinvestors.com/companies/news/1099225/tiziana-doses-first-three-patients-in-als-trial-of-nasal-antibody-foralumab-1099225.html","published":"2026-09-28T13:14:00Z","seen":"2026-09-28T14:23:24Z","lang":"en","source":{"id":"proactiveinvestors.com","name":"proactiveinvestors.com","domain":"proactiveinvestors.com"},"via":"gdelt-gkg-english","topics":["economy","health","education","business"],"entities":[{"id":"Q206901","name":"amyotrophic lateral sclerosis","type":"event"}],"story":"st_esgaqwqh3y7x44xr5qkq","category":"health","category_p":0.7300000190734863,"sentiment":"neutral","tone":-0.05000000074505806,"political":0.10999999940395355}]}